A Safety, Tolerability, Pharmacokinetics (PK) and Target Engagement (TE) Study of GSK3858279 in Healthy Participants and Evaluation of the Efficacy of Repeat Doses in Participants With Osteoarthritis (OA)

NCT03485365 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

97

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain, Inflammatory

Interventions

DRUG: GSK3858279 IV
DRUG: GSK3858279 SC
DRUG: Placebo matching to GSK3858279 (SC or IV)
DRUG: Placebo matching to GSK3858279 (SC)

Sponsor

GlaxoSmithKline